Genentech Moves Rituxan Into Rheumatoid Arthritis, Readies Enbrel Supply

Genentech's Rituxan rheumatoid arthritis development program has been added to the company's pipeline as its fourth R&D project for 2002

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet